Skin, the largest and outermost organ, provides the most accessible way to administer medicine. Transdermal drug delivery (TDD), as an easier and more targeted administration method, has attracted extensive investigations.1–3 However, the stratum corneum (SC) blocks the penetration of drugs into the dermis, which limits the treatment outcome. In order to breach the barrier function of SC, various physical or chemical methods have been proposed, such as ultrasound,4 iontophoresis,5 electroporation,6 microneedles,7 plasma,8 and chemical enhancers.9 These methods have been successfully used to enhance the transdermal delivery of small molecules, lipophilic-preferred and low-dose drugs, but the delivery of macromolecules, hydrophilic drugs, vaccines, and new genetic treatment employings such as DNA or small-interfering RNA is still challenging.1